CORT
Corcept Therapeutics Incorporated
110.30$
-4.0%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 3.3% | 2.7% | 2.5% | 2.2% | 2.1% | 1.8% | 1.6% | 1.4% | 1.3% | 1.3% | 1.6% | 1.7% | |
| 96.7% | 97.3% | 97.5% | 97.8% | 97.9% | 98.2% | 98.4% | 98.6% | 98.7% | 98.7% | 98.4% | 98.3% | |
| 69.2% | 30.7% | 29.3% | 25.4% | 29.9% | 29.0% | 32.4% | 31.1% | 32.6% | 38.2% | 36.6% | 33.5% | |
| 131.5% | 73.5% | 55.6% | 39.2% | 32.4% | 32.7% | 29.8% | 33.4% | 38.0% | 38.2% | 41.5% | 58.9% | |
| 200.7% | 104.1% | 85.0% | 64.6% | 62.3% | 61.8% | 62.2% | 64.5% | 70.6% | 76.4% | 78.1% | 92.4% | |
| -104.0% | -6.8% | 12.5% | 33.2% | 35.6% | 36.4% | 36.2% | 34.0% | 28.0% | 22.2% | 20.3% | 5.9% | |
| 14.2% | 5.9% | 2.5% | 0.0% | 1.1% | 1.7% | 1.6% | 1.0% | 0.9% | – | – | – | |
| -118.2% | -12.7% | 10.0% | 33.2% | 36.7% | 38.1% | 37.2% | 34.2% | 28.9% | 25.8% | 23.9% | 8.7% | |
| 0.0% | 0.0% | 0.0% | -47.9% | 6.7% | 7.3% | 7.2% | 3.4% | 3.7% | 3.8% | 3.0% | -4.4% | |
| -118.2% | -12.7% | 10.0% | 81.1% | 30.0% | 30.7% | 30.0% | 30.7% | 25.2% | 22.0% | 20.7% | 13.1% | |
| -103.5% | -6.5% | 12.6% | 33.3% | 35.7% | 37.1% | 36.9% | 34.9% | 28.8% | 26.0% | 24.1% | 9.0% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.